Moffitt Cancer Center

Moffitt Cancer Center

This is your central portal for breaking news, the latest research and important updates from Moffitt Cancer Center. Bookmark this page and check back often for updates.

ASH presents Scholar Awards to fellows, junior faculty

December 22, 2019
ASH announced the recipients of its 2019 Scholar Awards. The awards — presented to hematologists in the United States and Canada who conduct…
Cover Story

Developing a Pause Button for CAR T-Cell Therapy

Cell Therapy Next, October/November 2019
Chimeric antigen receptor T-cell therapy has proven to be a life-changing development for those with advanced, treatment refractory leukemia and…

Is neoadjuvant immunotherapy the best treatment approach for regionally advanced Merkel cell carcinoma?

HemOnc Today, September 25, 2019
POINT Checkpoint inhibitors — specifically avelumab and pembrolizumab — have revolutionized the management of unresectable metastatic Merkel…
In the Journals

PTSD may increase risk for ovarian cancer

September 6, 2019
Symptoms of PTSD appeared associated with increased risk for ovarian cancer, especially among premenopausal women, according to study results…
In the Journals

HIV infection worsens cancer outcomes among elderly

August 1, 2019
Elderly patients with HIV and cancer appeared to have worse clinical outcomes than patients without HIV, according to results of a retrospective…

The University of Texas MD Anderson Cancer Center ranked best cancer hospital in nation

July 30, 2019
The University of Texas MD Anderson Cancer Center has retained its distinction as the No. 1 cancer hospital in the country. MD Anderson tops U.S
Meeting News

Experts at congressional briefing on HPV: It's 'time to end cervical cancer'

June 27, 2019
Experts at a congressional briefing today addressed the need for the U.S. to actively pursue the goal of eradicating HPV and its associated cancers…
Meeting NewsPerspective

Tumor-infiltrating lymphocyte therapy appears safe, effective in melanoma, cervical cancer

June 2, 2019
CHICAGO — Data from two trials evaluating the safety and efficacy of adoptive cell transfer with autologous tumor-infiltrating lymphocytes…

The Handoff: Transferring CAR T Patients Back to the Community Setting

Cell Therapy Next, May 2019
Julio C. Chavez, MD
In this installment of In Practice, Julio C. Chavez, MD, assistant member in the lymphoma section of the department of malignant hematology at…
Trend Watch

Medicare’s proposed CAR T reimbursement increase ‘woefully inadequate’

April 30, 2019
CMS has announced a proposed 15% increase in the amount it would reimburse hospitals for inpatient CAR T-cell therapy for Medicare patients. The…
Meeting NewsPerspective

Luspatercept effectively treats anemia in transfusion-dependent myelodysplastic syndrome

December 1, 2018
SAN DIEGO — Luspatercept significantly reduced the transfusion burden compared with placebo among patients with anemia due to myelodysplastic…

Trove of brain cancer data available for study through Georgetown platform

November 27, 2018
One of the largest collections of brain cancer biomedical data in the United States is now available for study through the open access Georgetown…
In the Journals

Midlife PSA levels predict risk for aggressive prostate cancer among black men

November 27, 2018
Baseline PSA levels obtained during midlife appeared to predict the long-term risk for aggressive prostate cancer among a cohort of black men…

Large study of black men with prostate cancer to look beyond genetics

November 26, 2018
Researchers at Keck School of Medicine of USC are leading a $26.5 million effort to conduct the first large-scale study of black men with prostate…
Meeting NewsPerspective

Cisplatin with radiation ‘standard of care’ for HPV-related oral cancers

October 24, 2018
Chemoradiotherapy produced superior survival outcomes compared with radiation and cetuximab in a cohort of patients with HPV-associated oropharyngeal…
In the Journals

Regular aspirin use may lower risk for ovarian, liver cancers

October 4, 2018
Regular use of aspirin at specific doses appeared to decreased risk for ovarian cancer and hepatocellular carcinoma, according to two separate…
Meeting NewsPerspective

Durvalumab extends OS in advanced lung cancer

September 28, 2018
Durvalumab prolonged OS among patients with locally advanced, unresectable stage III non-small cell lung cancer that did not progress following…
Cover Story

Physician, patient education needed to increase lung cancer screening rate

HemOnc Today, September 25, 2018
When the U.S. Preventive Services Task Force endorsed lung cancer screening for Americans who meet age and smoking history criteria, proponents…
In the Journals

Dose-dense chemotherapy improves bladder cancer outcomes following cystectomy

September 18, 2018
Neoadjuvant chemotherapy comprised of a dose-dense combination of methotrexate, vinblastine, doxorubicin and cisplatin improved response rates among…

Daily aspirin may reduce ovarian cancer risk, extend survival

September 13, 2018
The use of aspirin daily may reduce ovarian cancer risk as well as improve survival after diagnosis, according to two separate studies. …